Physiological and pathophysiological regulation of cytochrome P450

被引:0
|
作者
Morgan, ET [1 ]
Sewer, MB
Iber, H
Gonzalez, FJ
Lee, YH
Tukey, RH
Okino, S
Vu, T
Chen, YH
Sidhu, JS
Omiecinski, CJ
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[2] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA
[3] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA
[4] Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article is a report on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics and held at the April 1998 Experimental Biology '98 meeting in San Francisco. The presentations focused on the mechanisms of regulation of cytochrome P450 gene expression by developmental factors and by hormones and cytokines, as well as on the interplay between physiological and chemical regulation. Approaches and systems used to address these questions included conditional gene knockouts in mice, primary hepatocyte cultures, immunofluorescence imaging of cells, and cell lines stably expressing reporter gene constructs.
引用
收藏
页码:1232 / 1240
页数:9
相关论文
共 50 条
  • [31] Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase
    Guengerich, F. Peter
    Martin, Martha V.
    Sohl, Christal D.
    Cheng, Qian
    NATURE PROTOCOLS, 2009, 4 (09) : 1245 - 1251
  • [32] Cytochrome p450 recognition sites for NADPH cytochrome p450 reductase
    Dai, R
    Robinson, RC
    Friedman, FK
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : SU162 - SU162
  • [33] Regulation of liver cytochrome P450 by activation of brain dopaminergic system:: Physiological and pharmacological implications
    Wojcikowski, Jacek
    Golembiowska, Krystyna
    Daniel, Wladyslawa Anna
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (02) : 258 - 267
  • [34] A Pathophysiological Role of Cytochrome P450 Involved in Production of Reactive Oxygen Species
    Shimamoto, Norio
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2013, 133 (04): : 435 - 450
  • [35] Cytochrome P450 endoplasmic reticulumassociated degradation(ERAD): therapeutic and pathophysiological implications
    Doyoung Kwon
    Sung-Mi Kim
    Maria Almira Correia
    ActaPharmaceuticaSinicaB, 2020, 10 (01) : 42 - 60
  • [36] THE REGULATION OF CYTOCHROME-P-450S (P450) INACTIVATED BY ALLYLISOPROPYLACETAMIDE (AIA)
    BORNHEIM, LM
    UNDERWOOD, M
    RETTIE, AE
    TRAGER, WF
    CORREIA, MA
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1665 - 1665
  • [37] Human Cytochrome P450 Interactions with Redox Partner Cytochrome P450 Reductase
    Burris-Hiday, Sarah
    Chai, Mengqi
    Gross, Michael L.
    Scott, Emily
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [38] Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450
    Miyamoto, Masayoshi
    Yamashita, Taku
    Yasuhara, Yuki
    Hayasaki, Akinori
    Hosokawa, Yukari
    Tsujino, Hirofumi
    Uno, Tadayuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2015, 63 (04) : 286 - 294
  • [39] Sphingomyelin hydrolysis and regulation of the expression of the gene for cytochrome P450
    Merrill, AH
    Morgan, ET
    Nikolova-Karakashian, M
    Stewart, J
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (04) : 383 - 387
  • [40] The role of the arcuate nucleus in the regulation of cytochrome P450 in the liver
    Bromek, E.
    Wojcikowski, J.
    Daniel, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 225 - 225